Old Mutual Global Investors UK Ltd. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,301 shares of the financial services provider’s stock, valued at approximately $162,000.

A number of other large investors have also recently modified their holdings of the business. Guardian Life Insurance Co. of America lifted its holdings in shares of CME Group by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock worth $156,000 after buying an additional 9 shares in the last quarter. Honkamp Krueger Financial Services Inc. lifted its holdings in shares of CME Group by 0.4% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock worth $368,000 after buying an additional 13 shares in the last quarter. Pitcairn Co. lifted its holdings in shares of CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock worth $386,000 after buying an additional 14 shares in the last quarter. Buffington Mohr McNeal lifted its holdings in shares of CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock worth $570,000 after buying an additional 15 shares in the last quarter. Finally, Summit Asset Management LLC lifted its holdings in shares of CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock worth $358,000 after buying an additional 16 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts have recently commented on the stock. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday. Barclays PLC initiated coverage on shares of CME Group in a report on Friday, September 8th. They issued an “overweight” rating and a $139.00 target price on the stock. UBS AG reaffirmed a “buy” rating and set a $135.00 price target (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 price target on shares of CME Group in a research note on Friday, August 18th. Finally, Royal Bank Of Canada set a $135.00 price target on shares of CME Group and gave the company a “buy” rating in a research note on Tuesday, August 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $132.56.

In other news, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Monday, July 10th. The stock was sold at an average price of $124.50, for a total transaction of $311,250.00. Following the transaction, the chief financial officer now owns 38,495 shares in the company, valued at approximately $4,792,627.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, President Bryan T. Durkin sold 9,200 shares of CME Group stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the transaction, the president now owns 70,938 shares in the company, valued at approximately $8,876,471.94. The disclosure for this sale can be found here. Insiders sold a total of 48,244 shares of company stock worth $6,021,890 in the last 90 days. 0.57% of the stock is currently owned by insiders.

Shares of CME Group Inc. (NASDAQ:CME) opened at 130.06 on Wednesday. CME Group Inc. has a 1-year low of $98.95 and a 1-year high of $130.15. The company’s 50-day moving average is $125.07 and its 200-day moving average is $121.81. The stock has a market cap of $44.21 billion, a P/E ratio of 26.55 and a beta of 0.72.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The company had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 EPS. Equities analysts expect that CME Group Inc. will post $4.81 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a yield of 2.03%. CME Group’s payout ratio is currently 53.99%.

TRADEMARK VIOLATION NOTICE: This story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/09/13/old-mutual-global-investors-uk-ltd-invests-162000-in-cme-group-inc-cme-stock.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.